
AuId	1389051172
now_work_for	1283280774
History_Afflication	
harvard medical school	1987-2016
brigham and women s hospital	1991-2016
None	1981-2016

Fields	

Field_Name	medicine
label_color	#9400D3


Field_Name	diabetes mellitus
label_color	rgb(92, 184, 92)


Field_Name	myocardial infarction
label_color	rgb(92, 184, 92)

first_page_year	1981
now_year	2016
Author_Name	paul m ridker
total_CC	45380
first author paper	

Publish Journal	n engl j med
Publish Year	2009
Cited Num	3651
Title	C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women


Publish Journal	n engl j med
Publish Year	2009
Cited Num	3561
Title	Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men


Publish Journal	n engl j med
Publish Year	2009
Cited Num	2838
Title	Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein


Publish Journal	acc current journal review
Publish Year	2009
Cited Num	2318
Title	Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events


Publish Journal	circulation
Publish Year	2000
Cited Num	1418
Title	Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men


Publish Journal	circulation
Publish Year	2003
Cited Num	1392
Title	C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events An 8-Year Follow-Up of 14 719 Initially Healthy American Women


Publish Journal	n engl j med
Publish Year	2009
Cited Num	1387
Title	C-Reactive Protein Levels and Outcomes after Statin Therapy


Publish Journal	circulation
Publish Year	2003
Cited Num	1339
Title	Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention


Publish Journal	acc current journal review
Publish Year	2009
Cited Num	1161
Title	A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women


Publish Journal	circulation
Publish Year	1998
Cited Num	1155
Title	Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women


Publish Journal	acc current journal review
Publish Year	2009
Cited Num	1034
Title	Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events


Publish Journal	circulation
Publish Year	1999
Cited Num	955
Title	Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein


Publish Journal	circulation
Publish Year	2001
Cited Num	905
Title	High-Sensitivity C-Reactive Protein Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease


Publish Journal	jama
Publish Year	2007
Cited Num	898
Title	Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.


Publish Journal	lancet
Publish Year	1998
Cited Num	839
Title	Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men


Publish Journal	circulation
Publish Year	1998
Cited Num	817
Title	Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels


Publish Journal	jama
Publish Year	2001
Cited Num	791
Title	Novel Risk Factors for Systemic Atherosclerosis: A Comparison of C-Reactive Protein, Fibrinogen, Homocysteine, Lipoprotein(a), and Standard Cholesterol Screening as Predictors of Peripheral Arterial Disease


Publish Journal	circulation
Publish Year	1999
Cited Num	742
Title	Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.


Publish Journal	circulation
Publish Year	1998
Cited Num	721
Title	C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction


Publish Journal	n engl j med
Publish Year	2009
Cited Num	647
Title	Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.


Publish Journal	circulation
Publish Year	1998
Cited Num	633
Title	Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease


Publish Journal	circulation
Publish Year	1998
Cited Num	627
Title	Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.


Publish Journal	circulation
Publish Year	2000
Cited Num	573
Title	Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction


Publish Journal	lancet
Publish Year	2009
Cited Num	517
Title	Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial


Publish Journal	acc current journal review
Publish Year	2009
Cited Num	482
Title	Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism


Publish Journal	lancet
Publish Year	1993
Cited Num	453
Title	Endogenous tissue-type plasminogen activator and risk of myocardial infarction


Publish Journal	circulation
Publish Year	2008
Cited Num	444
Title	C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction The Reynolds Risk Score for Men


Publish Journal	jama
Publish Year	2005
Cited Num	428
Title	Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.


Publish Journal	circulation
Publish Year	2004
Cited Num	409
Title	Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?


Publish Journal	jama
Publish Year	1993
Cited Num	391
Title	A prospective study of lipoprotein(a) and the risk of myocardial infarction.


Publish Journal	circulation
Publish Year	2001
Cited Num	364
Title	Soluble P-Selectin and the Risk of Future Cardiovascular Events


Publish Journal	circulation
Publish Year	1999
Cited Num	350
Title	Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein


Publish Journal	jama
Publish Year	1997
Cited Num	342
Title	ETHNIC DISTRIBUTION OF FACTOR V LEIDEN IN 4047 MEN AND WOMEN. IMPLICATIONS FOR VENOUS THROMBOEMBOLISM SCREENING


Publish Journal	circulation
Publish Year	2001
Cited Num	330
Title	Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia


Publish Journal	j amer coll cardiol
Publish Year	2007
Cited Num	317
Title	C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.


Publish Journal	circulation
Publish Year	2004
Cited Num	310
Title	Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores


Publish Journal	circulation
Publish Year	2004
Cited Num	299
Title	Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events


Publish Journal	circulation
Publish Year	2003
Cited Num	293
Title	Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein Rationale and Design of the JUPITER Trial


Publish Journal	circulation
Publish Year	1993
Cited Num	259
Title	Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.


Publish Journal	amer heart j
Publish Year	2011
Cited Num	253
Title	Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)


Publish Journal	lancet
Publish Year	2012
Cited Num	230
Title	Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial


Publish Journal	lancet
Publish Year	1994
Cited Num	229
Title	Prospective study of endogenous tissue plasminogen activator and risk of stroke


Publish Journal	jama
Publish Year	1994
Cited Num	226
Title	Association of Moderate Alcohol Consumption and Plasma Concentration of Endogenous Tissue-Type Plasminogen Activator


Publish Journal	ann intern med
Publish Year	1999
Cited Num	225
Title	Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?


Publish Journal	lancet
Publish Year	1997
Cited Num	219
Title	PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis.


Publish Journal	circulation
Publish Year	1997
Cited Num	217
Title	Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism


Publish Journal	circulation
Publish Year	1990
Cited Num	210
Title	Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.


Publish Journal	lancet
Publish Year	2013
Cited Num	201
Title	Statins: new American guidelines for prevention of cardiovascular disease


Publish Journal	amer j hum genet
Publish Year	2008
Cited Num	193
Title	Loci Related to Metabolic-Syndrome Pathways Including LEPR,HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study


Publish Journal	j amer coll cardiol
Publish Year	2007
Cited Num	176
Title	C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk


Publish Journal	circulation
Publish Year	1995
Cited Num	173
Title	Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.


Publish Journal	jama
Publish Year	1999
Cited Num	173
Title	Homocysteine and risk of cardiovascular disease among postmenopausal women


Publish Journal	circulation
Publish Year	1999
Cited Num	170
Title	G20210A Mutation in Prothrombin Gene and Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in a Large Cohort of US Men


Publish Journal	circulation
Publish Year	1999
Cited Num	165
Title	Prospective Study of Chlamydia pneumoniae IgG Seropositivity and Risks of Future Myocardial Infarction


Publish Journal	amer heart j
Publish Year	2004
Cited Num	164
Title	High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit


Publish Journal	circulation
Publish Year	2003
Cited Num	163
Title	C-Reactive Protein A Simple Test to Help Predict Risk of Heart Attack and Stroke


Publish Journal	lancet
Publish Year	2012
Cited Num	160
Title	Cardiovascular Benefits and Diabetes Risks of Statin Therapy in Primary Prevention


Publish Journal	amer j cardiol
Publish Year	2003
Cited Num	159
Title	High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention


Publish Journal	jama
Publish Year	2006
Cited Num	155
Title	Reported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-for-Profit Organizations: 2000-2005


Publish Journal	j thromb haemost
Publish Year	2009
Cited Num	154
Title	Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)


Publish Journal	circulation
Publish Year	1994
Cited Num	151
Title	Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.


Publish Journal	ann intern med
Publish Year	1998
Cited Num	145
Title	Factor V Leiden Mutation as a Risk Factor for Recurrent Pregnancy Loss


Publish Journal	nutr rev
Publish Year	2007
Cited Num	144
Title	Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity


Publish Journal	circulation
Publish Year	1997
Cited Num	140
Title	Arterial and Venous Thrombosis Is Not Associated With the 4G/5G Polymorphism in the Promoter of the Plasminogen Activator Inhibitor Gene in a Large Cohort of US Men


Publish Journal	j amer coll cardiol
Publish Year	2005
Cited Num	130
Title	Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.


Publish Journal	circulation
Publish Year	1998
Cited Num	125
Title	Prospective Study of Herpes Simplex Virus, Cytomegalovirus, and the Risk of Future Myocardial Infarction and Stroke


Publish Journal	lancet
Publish Year	2010
Cited Num	121
Title	HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial


Publish Journal	j periodontol
Publish Year	2008
Cited Num	119
Title	Inflammation, C-Reactive Protein, and Atherothrombosis


Publish Journal	ann intern med
Publish Year	1991
Cited Num	115
Title	Low-Dose Aspirin Therapy for Chronic Stable Angina: A Randomized, Placebo-Controlled Clinical Trial


Publish Journal	cardiol clin
Publish Year	2003
Cited Num	109
Title	C-reactive protein, inflammation, and coronary risk ☆


Publish Journal	j amer coll cardiol
Publish Year	2005
Cited Num	108
Title	Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dl and C-Reactive Protein <2 mg/l


Publish Journal	j amer coll cardiol
Publish Year	2010
Cited Num	103
Title	Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein : A Secondary Analysis From the JUPITER (Justification for the Use of Statins in Prevention–an Intervention Trial Evaluating Rosuvastatin) Trial


Publish Journal	clin chem
Publish Year	2008
Cited Num	102
Title	Rationale, Design, and Methodology of the Women’s Genome Health Study: A Genome-Wide Association Study of More Than 25 000 Initially Healthy American Women


Publish Journal	hypertension
Publish Year	2006
Cited Num	100
Title	Valsartan, Blood Pressure Reduction, and C-Reactive Protein Primary Report of the Val-MARC Trial


Publish Journal	circulation
Publish Year	2003
Cited Num	99
Title	Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke.


Publish Journal	circulation
Publish Year	2002
Cited Num	98
Title	On Evolutionary Biology, Inflammation, Infection, and the Causes of Atherosclerosis


Publish Journal	ann intern med
Publish Year	1999
Cited Num	96
Title	Baseline IgG Antibody Titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes Simplex Virus, and Cytomegalovirus and the Risk for Cardiovascular Disease in Women


Publish Journal	lancet
Publish Year	2001
Cited Num	96
Title	Role of inflammatory biomarkers in prediction of coronary heart disease


Publish Journal	circulation
Publish Year	2012
Cited Num	91
Title	Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen A Phase IIb Randomized, Placebo-Controlled Trial


Publish Journal	jama
Publish Year	1995
Cited Num	90
Title	Plasma Concentration of Lipoprotein(a) and the Risk of Future Stroke


Publish Journal	circ cardiovasc genet
Publish Year	2009
Cited Num	89
Title	Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction Genomewide Analysis Among 18 245 Initially Healthy Women From the Women’s Genome Health Study


Publish Journal	circulation
Publish Year	1998
Cited Num	88
Title	Inflammation, Infection, and Cardiovascular Risk How Good Is the Clinical Evidence?


Publish Journal	amer j cardiol
Publish Year	2007
Cited Num	87
Title	Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein


Publish Journal	arterioscler thromb vasc biol
Publish Year	2003
Cited Num	85
Title	Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.


Publish Journal	ann intern med
Publish Year	1997
Cited Num	84
Title	Age-Specific Incidence Rates of Venous Thromboembolism among Heterozygous Carriers of Factor V Leiden Mutation


Publish Journal	eur heart j
Publish Year	2014
Cited Num	83
Title	Anti-inflammatory therapies for cardiovascular disease


Publish Year	1998
Cited Num	78
Title	Prospective studies of C-reactive protein as a risk factor for cardiovascular disease.


Publish Journal	gastroenterology
Publish Year	1985
Cited Num	76
Title	Hepatic Venocclusive Disease Associated With the Consumption of Pyrrolizidine Containing Dietary Supplements


Publish Journal	clin chem
Publish Year	2009
Cited Num	71
Title	C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease


Publish Year	2007
Cited Num	70
Title	Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women


Publish Journal	amer j cardiol
Publish Year	2010
Cited Num	70
Title	Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).


Publish Journal	n engl j med
Publish Year	2004
Cited Num	68
Title	C-reactive protein and coronary heart disease.


Publish Journal	circ cardiovasc qual outcomes
Publish Year	2009
Cited Num	68
Title	Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)


Publish Year	2000
Cited Num	61
Title	Novel risk factors and markers for coronary disease.


Publish Journal	eur heart j
Publish Year	1998
Cited Num	57
Title	C-reactive protein and risks of future myocardial infarction and thrombotic stroke.


Publish Journal	clin chem
Publish Year	2008
Cited Num	54
Title	Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?


Publish Journal	current atherosclerosis reports
Publish Year	2003
Cited Num	53
Title	C-reactive protein and risk of cardiovascular disease: Evidence and clinical application


Publish Journal	current atherosclerosis reports
Publish Year	2013
Cited Num	53
Title	Moving Beyond JUPITER: Will Inhibiting Inflammation Reduce Vascular Event Rates?


Publish Journal	ann intern med
Publish Year	2001
Cited Num	43
Title	A Prospective Study of Helicobacter pylori Seropositivity and the Risk for Future Myocardial Infarction among Socioeconomically Similar U.S. Men


Publish Journal	circulation
Publish Year	2002
Cited Num	42
Title	Inflammatory Biomarkers, Statins, and the Risk of Stroke Cracking a Clinical Conundrum


Publish Journal	eur heart j
Publish Year	2001
Cited Num	41
Title	Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial.


Publish Journal	circulation
Publish Year	1992
Cited Num	39
Title	Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.


Publish Journal	circulation
Publish Year	2002
Cited Num	39
Title	Plasma Homocysteine Concentration, Statin Therapy, and the Risk of First Acute Coronary Events


Publish Journal	lancet
Publish Year	2014
Cited Num	38
Title	LDL cholesterol: controversies and future therapeutic directions


Publish Journal	amer heart j
Publish Year	1991
Cited Num	37
Title	The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: Clinical evidence from the physicians' health study


Publish Journal	ann intern med
Publish Year	1993
Cited Num	36
Title	Large-Scale Trials of Thrombolytic Therapy for Acute Myocardial Infarction: GISSI-2, ISIS-3, and GUSTO-1


Publish Journal	n engl j med
Publish Year	2007
Cited Num	35
Title	Biomarkers for prediction of cardiovascular events.


Publish Journal	lancet
Publish Year	2014
Cited Num	35
Title	Refining the American guidelines for prevention of cardiovascular disease – Authors' reply


Publish Journal	arterioscler thromb vasc biol
Publish Year	1997
Cited Num	33
Title	Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men.


Publish Journal	texas heart institute journal
Publish Year	2005
Cited Num	33
Title	C-Reactive Protein, Inflammation, and Cardiovascular Disease: Clinical Update


Publish Journal	circ cardiovasc qual outcomes
Publish Year	2009
Cited Num	33
Title	The JUPITER Trial Results, Controversies, and Implications for Prevention


Publish Journal	clin cardiol
Publish Year	2003
Cited Num	32
Title	Connecting the role of C‐reactive protein and statins in cardiovascular disease


Publish Journal	lancet
Publish Year	1993
Cited Num	31
Title	Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction


Publish Journal	lancet
Publish Year	1999
Cited Num	29
Title	Assessment of genetic markers for coronary thrombosis: promise and precaution


Publish Journal	jama
Publish Year	2013
Cited Num	29
Title	A Trial-Based Approach to Statin Guidelines


Publish Journal	amer heart j
Publish Year	1991
Cited Num	27
Title	Bioprosthetic tricuspid valve stenosis associated with extensive plaque deposition in carcinoid heart disease


Publish Journal	amer j cardiol
Publish Year	1992
Cited Num	26
Title	Comparison of delay times to hospital presentation for physicians and nonphysicians with acute myocardial infarction


Publish Journal	circulation
Publish Year	2005
Cited Num	26
Title	Should Age and Time Be Eliminated From Cardiovascular Risk Prediction Models? Rationale for the Creation of a New National Risk Detection Program


Publish Journal	circ cardiovasc genet
Publish Year	2011
Cited Num	26
Title	Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.


Publish Journal	j cardiovasc risk
Publish Year	1996
Cited Num	25
Title	Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women


Publish Journal	clin chem
Publish Year	2012
Cited Num	24
Title	Relationship of Lipoprotein-Associated Phospholipase A2 Mass and Activity with Incident Vascular Events among Primary Prevention Patients Allocated to Placebo or to Statin Therapy: An Analysis from the JUPITER Trial


Publish Journal	ann intern med
Publish Year	1994
Cited Num	22
Title	A Response to “Holding GUSTO Up to the Light”


Publish Journal	circulation
Publish Year	1991
Cited Num	21
Title	Hemostatic risk factors for coronary heart disease.


Publish Journal	arch environ health
Publish Year	1987
Cited Num	20
Title	Toxic effects of herbal teas.


Publish Journal	amer j med
Publish Year	1989
Cited Num	19
Title	Streptokinase therapy and cholesterol embolization


Publish Journal	vasc med
Publish Year	1998
Cited Num	19
Title	Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial


Publish Journal	circ cardiovasc qual outcomes
Publish Year	2010
Cited Num	19
Title	Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year Risk Implications of the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial for “Intermediate Risk”


Publish Journal	clin chem
Publish Year	2008
Cited Num	18
Title	High-Sensitivity C-Reactive Protein as a Predictor of All-Cause Mortality: Implications for Research and Patient Care


Publish Journal	amer j cardiol
Publish Year	2010
Cited Num	17
Title	The JUPITER Trial: Responding to the Critics


Publish Journal	american heart hospital journal
Publish Year	2004
Cited Num	16
Title	Inflammation in atherothrombosis: how to use high-sensitivity C-reactive protein (hsCRP) in clinical practice.


Publish Journal	j thromb haemost
Publish Year	2004
Cited Num	16
Title	Long‐term low‐dose warfarin use is effective in the prevention of recurrent venous thromboembolism: yes


Publish Journal	arthritis rheumatism
Publish Year	2009
Cited Num	16
Title	Should patients with rheumatoid arthritis receive statin therapy


Publish Journal	eur heart j
Publish Year	2013
Cited Num	16
Title	C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care


Publish Journal	pathophysiol haemost thromb
Publish Year	1997
Cited Num	15
Title	Intrinsic Fibrinolytic Capacity and Systemic Inflammation: Novel Risk Factors for Arterial Thrombotic Disease


Publish Journal	n engl j med
Publish Year	2003
Cited Num	15
Title	Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.


Publish Journal	arterioscler thromb vasc biol
Publish Year	2008
Cited Num	15
Title	The Time for Cardiovascular Inflammation Reduction Trials Has Arrived How Low to Go for hsCRP


Publish Journal	amer j cardiol
Publish Year	2009
Cited Num	15
Title	The Editor's Roundtable: The JUPITER Trial—Initial Results and Clinical Implications


Publish Journal	j thromb thrombolysis
Publish Year	1994
Cited Num	14
Title	Plasma Concentration of Endogenous Tissue Plasminogen Activator and the Occurrence of Future Cardiovascular Events.


Publish Journal	current cardiology reports
Publish Year	2000
Cited Num	14
Title	Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluation.


Publish Journal	circulation
Publish Year	1991
Cited Num	13
Title	Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy.


Publish Journal	american family physician
Publish Year	1989
Cited Num	12
Title	Health hazards of unusual herbal teas.


Publish Journal	clinical cornerstone
Publish Year	2002
Cited Num	12
Title	Inherited risk factors for venous thromboembolism: implications for clinical practice.


Publish Journal	eur heart j
Publish Year	2014
Cited Num	12
Title	Targeting inflammatory pathways for the treatment of cardiovascular disease


Publish Journal	curr opin lipidol
Publish Year	1992
Cited Num	11
Title	An epidemiologic assessment of thrombotic risk factors for cardiovascular disease


Publish Journal	arterioscler thromb vasc biol
Publish Year	1993
Cited Num	11
Title	A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100.


Publish Journal	eur heart j
Publish Year	2010
Cited Num	11
Title	Psoriasis, inflammation, and vascular risk: a problem more than skin deep?


Publish Journal	circ cardiovasc genet
Publish Year	2011
Cited Num	11
Title	KIF6 Polymorphism and the Efficacy of Rosuvastatin in Primary Prevention


Publish Year	2009
Cited Num	10
Title	Obesity and Risk of Death


Publish Year	2013
Cited Num	10
Title	Closing the Loop on Inflammation and Atherothrombosis: Why Perform the Cirt and Cantos Trials?


Publish Journal	circ res
Publish Year	2014
Cited Num	10
Title	Inflammation, C-Reactive Protein, and Cardiovascular Disease Moving Past the Marker Versus Mediator Debate


Publish Journal	arch intern med
Publish Year	2006
Cited Num	9
Title	C-Reactive Protein and Cardiovascular Risk in the Framingham Study


Publish Journal	amer j med
Publish Year	1989
Cited Num	8
Title	Hepatotoxicity due to comfrey herb tea


Publish Journal	lancet
Publish Year	2009
Cited Num	8
Title	Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin


Publish Journal	chronobiol int
Publish Year	2010
Cited Num	8
Title	Aspirin, Platelet Aggregation, and the Circadian Variation of Acute Thrombotic Events


Publish Journal	circulation
Publish Year	1996
Cited Num	7
Title	Age and Thrombolytic Therapy


Publish Journal	acc current journal review
Publish Year	2005
Cited Num	7
Title	Non–HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women


Publish Journal	jama
Publish Year	2006
Cited Num	7
Title	Use of aspirin as primary prevention of cardiovascular events.


Publish Journal	current atherosclerosis reports
Publish Year	2009
Cited Num	7
Title	Moving toward new statin guidelines in a post-JUPITER world: Principles to consider


Publish Journal	j amer coll cardiol
Publish Year	2010
Cited Num	7
Title	Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein


Publish Year	2012
Cited Num	7
Title	Hyperlipidemia as an instigator of inflammation: inaugurating new approaches to vascular prevention.


Publish Journal	ann intern med
Publish Year	2015
Cited Num	7
Title	Comparing Cardiovascular Risk Prediction Scores


Publish Journal	amer j clin pathol
Publish Year	1990
Cited Num	6
Title	False positive mononucleosis screening test results associated with Klebsiella hepatic abscess.


Publish Journal	ann epidemiol
Publish Year	1994
Cited Num	6
Title	Lipoprotein(a) and risks of cardiovascular disease


Publish Journal	climacteric
Publish Year	2009
Cited Num	6
Title	Homocysteine and risk of cardiovascular disease among postmenopausal women


Publish Journal	clin chem
Publish Year	2010
Cited Num	6
Title	Establishing a clinical basis for hsCRP in the prevention and treatment of cardiovascular disease.


Publish Journal	clin chem
Publish Year	2010
Cited Num	6
Title	Statin Therapy for Low-LDL, High-hsCRP Patients: From JUPITER to CORONA


Publish Journal	trend cardiovasc med
Publish Year	1995
Cited Num	5
Title	An epidemiologic reassessment of lipoprotein(a) and atherothrombotic risk


Publish Journal	j thromb thrombolysis
Publish Year	1999
Cited Num	5
Title	Pathogenesis and pathology of coronary heart disease syndromes.


Publish Journal	n engl j med
Publish Year	2001
Cited Num	5
Title	Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.


Publish Journal	lancet
Publish Year	2010
Cited Num	5
Title	JUPITER, rosuvastatin, and the European Medicines Agency


Publish Journal	texas heart institute journal
Publish Year	2010
Cited Num	5
Title	Inflammation, high-sensitivity C-reactive protein, and vascular protection.


Publish Journal	lancet
Publish Year	2011
Cited Num	5
Title	C-reactive protein in the Heart Protection Study


Publish Journal	j thromb thrombolysis
Publish Year	1995
Cited Num	4
Title	Potential antithrombotic and fibrinolytic properties of the angiotensin converting enzyme inhibitors


Publish Journal	jama
Publish Year	2006
Cited Num	4
Title	Incomplete Financial Disclosure for Study of Funding and Outcomes in Major Cardiovascular Trials


Publish Journal	clin chem
Publish Year	2009
Cited Num	4
Title	Myocardial Infarction in a 72-Year-Old Woman with Low LDL-C and Increased hsCRP: Implications for Statin Therapy


Publish Journal	clin trials
Publish Year	2011
Cited Num	4
Title	A tale of three labels: translating the JUPITER trial data into regulatory claims


Publish Journal	ann intern med
Publish Year	1994
Cited Num	3
Title	More on the GUSTO Trial


Publish Journal	j thromb thrombolysis
Publish Year	1995
Cited Num	3
Title	Direct comparison of aspirin plus hirudin aspirin plus heparin, and aspirin alone among 12,000 patients with acute myocardial infarction not receiving thrombolysis: Rationale and design of the First American Study of Infarct Survival (ASIS-1)


Publish Journal	current cardiology reports
Publish Year	1999
Cited Num	3
Title	Duration and intensity of anticoagulation among patients with genetic predispositions to venous thrombosis


Publish Journal	jama
Publish Year	2007
Cited Num	3
Title	Algorithms for Assessing Cardiovascular Risk in Women—Reply


Publish Journal	circulation
Publish Year	2012
Cited Num	3
Title	Lipoprotein(a), Ethnicity, and Cardiovascular Risk Erasing a Paradox and Filling a Clinical Gap


Publish Journal	lancet
Publish Year	2012
Cited Num	3
Title	Coronary artery calcium for guiding statin treatment


Publish Journal	jama
Publish Year	2014
Cited Num	3
Title	Formulation of treatment recommendations for statins--reply.


Publish Journal	eur heart j
Publish Year	2015
Cited Num	3
Title	Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events


Publish Journal	eur heart j
Publish Year	2016
Cited Num	3
Title	Per cent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents


Publish Journal	fibrinolysis
Publish Year	1997
Cited Num	2
Title	Endogenous fibrinolytic function and risks of future myocardial infarction and stroke: observations from the Physicians' Health Study


Publish Journal	acc current journal review
Publish Year	2001
Cited Num	2
Title	Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease


Publish Journal	metab syndr relat disord
Publish Year	2010
Cited Num	2
Title	Interpretation of Mendelian Randomization Studies and the Search for Causal Pathways in Atherothrombosis: The Need for Caution


Publish Journal	arch intern med
Publish Year	2011
Cited Num	2
Title	Coronary Artery Calcium Scanning in Primary Prevention: A Conversation With Cardiology Fellows


Publish Journal	circ cardiovasc imaging
Publish Year	2011
Cited Num	2
Title	High-Sensitivity C-Reactive Protein, Vascular Imaging, and Vulnerable Plaque More Evidence to Support Trials of Antiinflammatory Therapy for Cardiovascular Risk Reduction


Publish Year	2014
Cited Num	2
Title	Plasma Levels of the Proinflammatory Chitin-Binding Glycoprotein YKL-40, Variation in the Chitinase 3-Like 1 Gene (CHI3L1), and Incident Cardiovascular Events


Publish Journal	j amer coll cardiol
Publish Year	2015
Cited Num	2
Title	A Proposal to Incorporate Trial Data Into a Hybrid ACC/AHA Algorithm for the Allocation of Statin Therapy in Primary Prevention


Publish Journal	circ res
Publish Year	2016
Cited Num	2
Title	From C-Reactive Protein to Interleukin-6 to Interleukin-1 Moving Upstream To Identify Novel Targets for Atheroprotection


Publish Journal	j pediat
Publish Year	1989
Cited Num	1
Title	Hepatic veno-occlusive disease and herbal teas


Publish Year	2002
Cited Num	1
Title	Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of


Publish Journal	jama
Publish Year	2005
Cited Num	1
Title	Risk Factors for Cardiovascular Disease in Women—Reply


Publish Journal	lancet
Publish Year	2009
Cited Num	1
Title	Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial – Authors' reply


Publish Journal	lancet
Publish Year	2010
Cited Num	1
Title	HDL cholesterol and residual risk of first cardiovascular events – Authors' reply


Publish Journal	the cardiology
Publish Year	2012
Cited Num	1
Title	Increased Mortality Rates in the JUPITER Trial


Publish Journal	circulation
Publish Year	2013
Cited Num	1
Title	Expanding Options for Scientific Publication Is More Always Better


Publish Journal	eur heart j
Publish Year	2016
Cited Num	1
Title	Monoclonal antibodies targeting PCSK9 and the search for prolonged duration of effect


Publish Journal	j ethnopharmacol
Publish Year	1988
Cited Num	0
Title	Toxic effects of herbal teas


Publish Journal	j amer coll cardiol
Publish Year	1990
Cited Num	0
Title	Time to presentation for acute mi in the us physicians' health study


Publish Journal	ann thorac surg
Publish Year	1991
Cited Num	0
Title	Surgical management of carcinoid heart disease


Publish Journal	n engl j med
Publish Year	1993
Cited Num	0
Title	Book Review Prognosis and Risk Assessment in Cardiovascular Disease Edited by Amar S. Kapoor and Bramah N. Singh. 578 pp., illustrated. New York, Churchill Livingstone, 1993. $79.95. 0-443-08768-7


Publish Journal	biomed pharmacotherapy
Publish Year	1993
Cited Num	0
Title	Endogenous tissue-type plasminogen activator and myocardial infarction


Publish Journal	jama
Publish Year	1994
Cited Num	0
Title	Lipoprotein(a) and Risk of Myocardial Infarction-Reply


Publish Journal	jama
Publish Year	1995
Cited Num	0
Title	Lipoprotein(a) Concentration and Risk of Atherothrombotic Disease-Reply


Publish Journal	jama
Publish Year	1995
Cited Num	0
Title	Alcohol Consumption and Tissue-Type Plasminogen Activator-Reply


Publish Journal	ann intern med
Publish Year	1996
Cited Num	0
Title	Megatrials for Clinical Decision Making


Publish Journal	gender development
Publish Year	1997
Cited Num	0
Title	Inflammation, Aspirin, and Cardiovascular Disease


Publish Year	1997
Cited Num	0
Title	allele in the 330 Japanese people in our study suggests that this allele does not have an important role in the risk of cardiovascular events in Japan.


Publish Journal	lancet
Publish Year	1997
Cited Num	0
Title	PIA1/A2 polymorphism of platelet glycoprotein Illa and risk of cardiovascular disease


Publish Journal	vasc med
Publish Year	1998
Cited Num	0
Title	Thrombosis and Thromboembolism: New Strategies for Improved Patient Care


Publish Year	1998
Cited Num	0
Title	Means of ascertaining an individual' s risk profile for atherosclerotic disease


Publish Year	1999
Cited Num	0
Title	Activated Protein C Resistance, Factor V Leiden, and Venous Thromboembolism


Publish Journal	obstet gynecol surv
Publish Year	2000
Cited Num	0
Title	Factor V Leiden Mutation As a Risk Factor for Recurrent Pregnancy Loss


Publish Year	2001
Cited Num	0
Title	Inflammatory markers for detection and prevention of diabetes mellitus


Publish Journal	n engl j med
Publish Year	2002
Cited Num	0
Title	Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.


Publish Journal	obstet gynecol surv
Publish Year	2003
Cited Num	0
Title	Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events


Publish Year	2003
Cited Num	0
Title	La anticoagulación de baja intensidad y larga duración es eficaz en la prevención de la tromboembolia venosa recurrente


Publish Journal	n engl j med
Publish Year	2003
Cited Num	0
Title	Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism


Publish Year	2004
Cited Num	0
Title	Method for preventing recurring venous thromboembolism using long-term low-intensity warfarin


Publish Year	2005
Cited Num	0
Title	ASA prevents stroke, not MI, in women.


Publish Journal	j vasc surg
Publish Year	2005
Cited Num	0
Title	C-reactive protein levels and outcomes after statin therapy


Publish Journal	j vasc surg
Publish Year	2005
Cited Num	0
Title	A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women


Publish Journal	obstet gynecol surv
Publish Year	2005
Cited Num	0
Title	A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women


Publish Journal	n engl j med
Publish Year	2005
Cited Num	0
Title	A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.


Publish Year	2005
Cited Num	0
Title	USE OF AN AGENT FOR LOWERING THE RISK OF CARDIOVASCULAR DISEASE


Publish Year	2005
Cited Num	0
Title	Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease


Publish Year	2007
Cited Num	0
Title	Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases


Publish Journal	circulation
Publish Year	2007
Cited Num	0
Title	Letter by Ridker and Everett Regarding Article, “The Inflammatory Hypothesis: Any Progress in Risk Stratification and Therapeutic Targets?”


Publish Journal	circulation
Publish Year	2008
Cited Num	0
Title	Abstract 5100: C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men


Publish Year	2009
Cited Num	0
Title	Publishing Title: Rosuvastatin in the Prevention of Stroke Among Men and Women with Elevated Levels of C- Reactive Protein: The JUPITER Trial


Publish Journal	atheroscler suppl
Publish Year	2009
Cited Num	0
Title	Abstract: S6-27 USING NOVEL RISK FACTORS IN CLINICAL TRIALS


Publish Journal	obstet gynecol surv
Publish Year	2009
Cited Num	0
Title	Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein


Publish Journal	j vasc surg
Publish Year	2009
Cited Num	0
Title	Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein


Publish Journal	obstet gynecol surv
Publish Year	2009
Cited Num	0
Title	Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin Trial


Publish Journal	j amer coll cardiol
Publish Year	2010
Cited Num	0
Title	EFFICACY OF ROSUVASTATIN AMONG MEN AND WOMEN WITH CHRONIC KIDNEY DISEASE AND ELEVATED HSCRP: THE JUPITER TRIAL


Publish Journal	j amer coll cardiol
Publish Year	2010
Cited Num	0
Title	EFFICACY OF ROSUVASTATIN IN PRIMARY PREVENTION ACCORDING TO BASELINE LEVELS OF HSCRP IN THE JUPITER TRIAL


Publish Journal	am j manag care
Publish Year	2010
Cited Num	0
Title	Statin therapy for elevated hsCRP: what are the public health implications?


Publish Year	2010
Cited Num	0
Title	Missing centenarians in Japan: a new ageism


Publish Year	2010
Cited Num	0
Title	aspirin in a randomized trial of physicians Circadian variation of acute myocardial infarction and the effect of low-dose


Publish Year	2010
Cited Num	0
Title	Screening as Predictors of Peripheral Arterial Disease Homocysteine, Lipoprotein(a), and Standard Cholesterol Comparison of C-Reactive Protein, Fibrinogen, Novel Risk Factors for Systemic Atherosclerosis: A


Publish Year	2011
Cited Num	0
Title	POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT


Publish Journal	j amer coll cardiol
Publish Year	2011
Cited Num	0
Title	KIF6 POLYMORPHISM AND THE EFFICACY OF STATIN THERAPY IN PRIMARY PREVENTION: DATA FROM THE JUPITER TRIAL


Publish Journal	j vasc surg
Publish Year	2012
Cited Num	0
Title	Cardiovascular Benefits and Diabetes Risks of Statin Therapy in Primary Prevention: An Analysis From the JUPITER Trial


Publish Journal	j amer coll cardiol
Publish Year	2012
Cited Num	0
Title	EFFECTS OF INTERLEUKIN-1β INHIBITION WITH CANAKINUMAB ON IL-6, FIBRINOGEN, AND HSCRP: A RANDOMIZED PLACEBO CONTROLLED TRIAL


Publish Year	2012
Cited Num	0
Title	Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes


Publish Journal	j amer coll cardiol
Publish Year	2016
Cited Num	0
Title	A Test in Context : High-Sensitivity C-Reactive Protein


Publish Journal	amer heart j
Publish Year	2016
Cited Num	0
Title	Evaluating Bococizumab, a Monoclonal Antibody to PCSK9, on Lipid Levels and Clinical Events in Broad Patient Groups With and Without Prior Cardiovascular Events: Rationale and Design of the SPIRE Lipid Lowering and SPIRE Cardiovascular Outcomes Trials


Publish Journal	eur heart j
Publish Year	2016
Cited Num	0
Title	Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin

academic_age	35
